
Eleven people in Belgium who had being using the controversial drug domperidone have died, L'Avenir newspaper reported Monday.
Domperidone, which is largely marketed under the name Motilium, is prescribed to combat feelings of nausea.
A recent report by the medical journal "Prescribe" said domperidone was responsible for the deaths of over 200 people in France in 2012.
According to the Federal Agency for Medicines and Health Products (FAMHP), 11 people taking domperidone have died in Belgium.
"With regard to patients treated with medications containing domperidone, 11 deaths were reported to the FAMHP," a statement on the medical professionals' platform MediPlanet said.
Of these, five were reported by medical professionals, meaning "the causal link between the adverse event and base drug domperidone is considered possible," according to the statement.
According to research, domperidone has negative effects on the heart, especially for those over 60.
In September 2014, sales of Motilium 60g suppositories were withdrawn in Belgium, following a decision by the European Commission stating domperidone was a potentially unsafe drug.
GMT 11:19 2018 Thursday ,13 December
Nine killed, 47 injured as high-speed train crashes in TurkeyGMT 10:36 2018 Wednesday ,12 December
Strasbourg shooting leaves 3 dead, 12 injuredGMT 09:59 2018 Friday ,07 December
Death toll climbs to five after Santo Domingo factory explosionGMT 09:50 2018 Friday ,07 December
At least 18 Afghan soldiers killed in Taliban attackGMT 13:50 2018 Thursday ,06 December
Two found, five missing after US Marine aircraft collide off JapanGMT 16:27 2018 Sunday ,02 December
Villages evacuated as northern Australia fires flare in extreme heatGMT 08:16 2018 Thursday ,29 November
10 killed, 19 wounded in Taliban attack in KabulGMT 14:07 2018 Sunday ,18 November
About 15,000 people killed in Russian road accidents in 2018 so far
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor